Comprehensive Gene Expression Analysis Detects Global Reduction of Proteasome Subunits in Schizophrenia

• Published in: Schizophrenia bulletin Vol. 47; no. 3; pp. 785 - 795
• Main Authors: Hertzberg, Libi, Maggio, Nicola, Muler, Inna, Yitzhaky, Assif, Majer, Michael, Haroutunian, Vahram, Zuk, Or, Katsel, Pavel, Domany, Eytan, Weiser, Mark
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 01.05.2021
• Subjects: Adult; Aged; Aged, 80 and over; Brain - enzymology; Datasets as Topic; Diagnosis; Down-Regulation; Female; Gene expression; Gene Expression Profiling; Humans; Male; Middle Aged; Proteasome Endopeptidase Complex - genetics; Proteasome Endopeptidase Complex - metabolism; Regular; Schizophrenia; Schizophrenia - enzymology; Schizophrenia - genetics; Temporal Lobe - enzymology; Transcriptome - genetics; postmortem brain samples; ubiquitin proteasome system; integrated analysis; gene expression
• ISSN: 0586-7614; 1745-1701; 1745-1701
• DOI: 10.1093/schbul/sbaa160

Abstract BackgroundThe main challenge in the study of schizophrenia is its high heterogeneity. While it is generally accepted that there exist several biological mechanisms that may define distinct schizophrenia subtypes, they have not been identified yet. We performed comprehensive gene expression analysis to search for molecular signals that differentiate schizophrenia patients from healthy controls and examined whether an identified signal was concentrated in a subgroup of the patients. MethodsTranscriptome sequencing of 14 superior temporal gyrus (STG) samples of subjects with schizophrenia and 15 matched controls from the Stanley Medical Research Institute (SMRI) was performed. Differential expression and pathway enrichment analysis results were compared to an independent cohort. Replicability was tested on 6 additional independent datasets. ResultsThe 2 STG cohorts showed high replicability. Pathway enrichment analysis of the down-regulated genes pointed to proteasome-related pathways. Meta-analysis of differential expression identified down-regulation of 12 of 39 proteasome subunit genes in schizophrenia. The signal of proteasome subunits down-regulation was replicated in 6 additional datasets (overall 8 cohorts with 267 schizophrenia and 266 control samples, from 5 brain regions). The signal was concentrated in a subgroup of patients with schizophrenia. ConclusionsWe detected global down-regulation of proteasome subunits in a subgroup of patients with schizophrenia. We hypothesize that the down-regulation of proteasome subunits leads to proteasome dysfunction that causes accumulation of ubiquitinated proteins, which has been recently detected in a subgroup of schizophrenia patients. Thus, down-regulation of proteasome subunits might define a biological subtype of schizophrenia.